awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37201658-89C6C4B3-FC3A-4A2D-A57A-11F32B9BA0B7
Q37201658-89C6C4B3-FC3A-4A2D-A57A-11F32B9BA0B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37201658-89C6C4B3-FC3A-4A2D-A57A-11F32B9BA0B7
Importance of achieving the composite endpoints in diabetes.
P2860
Q37201658-89C6C4B3-FC3A-4A2D-A57A-11F32B9BA0B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37201658-89C6C4B3-FC3A-4A2D-A57A-11F32B9BA0B7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e825ed361957bc2580058a9ee1a5eb078b66c8a3
P2860
Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study.